I have used for myself as a way of understanding this the metaphor or analogy, I guess, of a levee that we are worried about breaching.

one of the challenges we have in responding to climate change as a matter of public policy is that it can be a very abstract concept.

We've got a spare parts problem. We're cannibalizing planes that some say cost $64 million, others say more.

this is a continuation of this defense of mediocrity, and it bothers me tremendously.

We had asked the Marine Corps to compile a list of incidents and mishaps involving the MV-22 since the aircraft was approved for full rate reduction in 2005.

We must make sure that whatever equipment we buy, that it is the equipment that they need to carry out their mission.

We must get what we bargain for, period.

A lot of times this is based on politics.

Whatever we buy for the military, it must do no harm to them.

there appears to be a design problem with the V-22.

Believe me, those of us on the Small Business Committee were livid at the fact that this was included without consultation with the Small Business Committee.

Thank you very much for that testimony. Particularly, for some of the history, which I found very, very helpful.

I agree completely with you and other witnesses that NIH could rectify the problem with that amendment.

Well, let me welcome everyone to this hearing of the Small Business and Entrepreneurship Committee of the United States Senate.

Let me just point out my concern. Mr. Glover's testimony particularly underscores this, that there has been an historic hostility at NIH to allowing special allocations to small businesses within the innovative research program.

I think there is a general consensus of the importance of the SBIR program, that it will create jobs much more efficiently than the other recipients;

We have not taken advantage of the small, innovative companies that are out there that could help us a great deal with a relatively small amount of federal investment.

I want to talk about the current economic climate and how urgent it is for us to try to get some relief to innovative small companies.